Policy ForumDRUG ABUSE

The Heroin Prescribing Debate: Integrating Science and Politics

See allHide authors and affiliations

Science  21 May 1999:
Vol. 284, Issue 5418, pp. 1277-1278
DOI: 10.1126/science.284.5418.1277

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


People dependent on heroin who do not respond to other treatments have been treated by a combination of heroin and methadone. In this Policy Forum, Bammer et al. argue that the debate about the merits of this treatment could be substantially informed by clinical trials that meet rigorous scientific standards. Because of the complexities of working with the dependent user population and the social and individual risks associated with this potential treatment, a series of interlocking trials with various designs and control groups are essential, and social impacts must also be monitored. Heroin will always be a second- rather than first-choice treatment, and if trials show that it has any value, the political outcome will be medicalization, not legalization.